Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom

Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene therapy and cardiometabolic disease. The plans follow U.S. capital expenditure announcements from several big pharmaceutical companies. The post Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom appeared first on…

Read More

MedCity FemFwd: The Complicated History Behind Hormone Replacement Therapy

[Sponsored] In this episode, we’re joined by Janna Manjelievskaia, director of health economics and outcomes research at Veradigm. We discuss Veradigm’s recent Women’s Health Insights Report, which highlights the complicated history around Hormone Replacement Therapy (HRT), a medication used to treat menopause. The post MedCity FemFwd: The Complicated History Behind Hormone Replacement Therapy appeared first…

Read More

Crothall Teams Awarded University of Chicago Medicine’s Supplier Community Impact Award

Crothall’s Environmental Services (EVS) and Patient Transport teams have received the University of Chicago Medicine (UChicago Medicine) Supplier Community Impact Award for their commitment to creating opportunities and making a difference in the local community. The recognition reflects the teams’ impact both inside and outside the hospital. Inclusive hiring practices, associate development, and driving sustainability…

Read More